Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 3, 2004, Pages 698-704

  Maguire, P D ^a,b   Meyerson, M B ^a   Neal, C R ^a   Hamann, M S ^a   Bost, A L ^a   Anagnost, J W ^a   Ungaro, P C ^a   Pollock, H D ^a   McMurray, J E ^a   Wilson, E P ^a   Kotwall, C A ^a  

^a NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

^b New Hanover Community Health Center   (United States)

Author keywords

Combined modality therapy; Hyperfractionation; Squamous cell carcinoma

Indexed keywords

CELLS; IRRADIATION; PATIENT TREATMENT; TOXIC MATERIALS; TOXICITY; TUMORS;

CHEMOIRRADIATION; HYPERFRACTIONATED RADIOTHERAPY;

ONCOLOGY;

CISPLATIN; FLUOROURACIL;

ACUTE TOXICITY; ADULT; ALCOHOLIC CARDIOMYOPATHY; ARTICLE; BACTEREMIA; BLOOD TOXICITY; BOLUS INJECTION; BONE DISEASE; BONE MARROW TOXICITY; BONE NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHONDRITIS; CLINICAL ARTICLE; COMMUNITY CARE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DYSPHAGIA; ELECTROLYTE DISTURBANCE; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEMATOLOGIC DISEASE; HUMAN; HYPERBARIC OXYGEN; LARYNX CHONDRITIS; LARYNX DISORDER; LARYNX EDEMA; LUNG EMBOLISM; MALE; MANDIBLE FRACTURE; MUCOSA TOXICITY; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PERIPHERAL NEUROPATHY; PERITONITIS; PHARYNX DISEASE; PHARYNX STRICTURE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SIDE EFFECT; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TRACHEOTOMY; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 10744228417     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)01576-1     Document Type: Article

References (28)

1. Weller S.A., Goffnet D.R., Goode R.L., et al. Carcinoma of the oropharynx Results of megavoltage radiation therapy in 305 patients . AJR Am J Roentgenol Radium Ther Nucl Med. 126:1976;236-247.
2. Mendenhall W.M., Parsons J.T., Cassisi N.J., et al. Squamous cell carcinoma of the tonsillar area treated with radical irradiation. Radiother Oncol. 10:1987;23-30.
3. Wendt C.D., Peters L.J., Ang K.K., et al. Hyperfractionated radiotherapy in the treatment of squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys. 17:1989;1057-1062.
4. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 19:1990;1339-1345.
5. Parsons J.T., Mendenhall W.M., Stringer S., et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck The University of Florida experience . Head Neck. 15:1993;87-96.
6. Garden A.S., Morrison W.H., Ang K.K., et al. Hyperfractionated radiation in the treatment of squamous cell cancers of the head and neck A comparison of two fractionation schedules . Int J Radiat Oncol Biol Phys. 31:1995;493-502.
7. Fein D., Lee W., Amos W., et al. Oropharyngeal carcinoma treated with radiotherapy A 30-year experience . Int J Radiat Oncol Biol Phys. 34:1996;289-296.
8. Wang C.C., Nakfoor B.M., Spiro I.J., et al. Role of accelerated fractionated irradiation for supraglottic carcinoma Assessment of results . Cancer J Sci Am. 3:1997;88-91.
9. Pinto L., Canary P., Araujo C., et al. Prospective randomized trial comparing hyperfractionated vs conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 21:1991;557-562.
10. Horiot J.C., LeFur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy . Radiother Oncol. 25:1992;231-241.
11. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial . Radiother Oncol. 44:1997;111-121.
12. Fu K., Pajak T., Trotti A., et al. A Radiation Therapy Oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas First report of RTOG 9003 . Int J Radiat Oncol Biol Phys. 48:2000;7-16.
13. Wolf G.T., Kong W.K., Fisher S.G., Urba S., et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 324:1991;1685-1690.
14. Lefebvre J.L., Chevalier D., Luboinski B., et al. Larynx preservation in pyriform sinus cancer Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial . J Natl Cancer Inst. 88:1996;890-899.
15. Munro A.J. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Oncol. 71:1995;83-91.
16. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma Three meta-analyses of up-dated individual data . Lancet. 355:2000;949-955.
17. Brizel D.M., Leopold K.A., Fisher S.R., et al. A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 28:1993;213-220.
18. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 338:1998;1798-1804.
19. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
20. Al-Sarraf M., LeBlanc M., Giri P.S., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer A phase III randomized Intergroup study 0099 . J Clin Oncol. 16:1998;1310-1317.
21. Adelstein D.J., Li Y., Adams G.L., et al. An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 21:2003;92-98.
22. Adelstein D.J., Saxton J.P., Lavertu P., et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in respectable stage III and IV squamous cell head and neck cancer Preliminary results . Head Neck. 19:1997;567-575.
23. Kies M.S., Haraf D.J., Rosen F., et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 19:2001;1961-1969.
24. Lavertu P., Adelstein D.J., Saxton J.P., et al. Management of the neck in a randomized trial comparing chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck. 19:1997;559-566.
25. Sanguineti G., Corvo R., Benasso M., et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck. 21:1999;223-228.
26. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 18:2000;4110-4111.
27. Anne P.R. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer. Semin Oncol. 29:(Suppl. 9):2002;80-83.
28. Chao K.S. Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer. Semin Radiat Oncol. 12:(Suppl. 1):2002;20-25.